DR. CONSTANCE TRANDAFIR DUTTON, N.D.
Dietitian and Nutritionist at Costa Verde Blvd, San Diego, CA
License number
California ND358
Category
Naturopathic
Type
Naturopath
Address
Address
2
8950 Costa Verde Blvd #4326, San Diego, CA 92122
530 Lomas Sant Fe Dr SUITE B-1, Solana Beach, CA 92075
530 Lomas Sant Fe Dr SUITE B-1, Solana Beach, CA 92075
Phone
(425) 802-5462
(858) 755-8959 (Fax)
(858) 755-8959 (Fax)
Professional information
Constance T Dutton, San Diego CA - ND (Doctor of Naturopathic Medicine)
Specialties:
Naturopathy
Address:
8950 Costa Verde Blvd STE 4326, San Diego 92122
(858) 755-8959 (Fax)
(858) 755-8959 (Fax)
Languages:
English
Methods For Chronic Pain Management And Treatment Using Hcg
US Patent:
2012026, Oct 18, 2012
Filed:
Dec 5, 2011
Appl. No.:
13/311250
Inventors:
Constance T. Dutton - San Diego CA, US
Assignee:
NEURALIGHT HD, LLC - Incline Village NV
International Classification:
A61M 5/31, A61M 5/178, A61P 25/00, A61K 38/24, A61K 9/12
US Classification:
604 92, 514 98, 424 45, 604207, 604187
Abstract:
A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided with at least one of human chorionic gonadotropin (uHCG and/or rHCG), a pharmaceutically active HCG analogue, and a pharmaceutically active metabolite of the HCG or analogue at a dosage selected to provide, or be equivalent to, a human subcutaneous dosage of between 120 IU/day and 170 IU/day of HCG, and more preferably between 140 IU/day and 160 IU/day of HCG. A kit is also described, which includes a supply of the HCG-related drug, a delivery device, and a label that identifies chronic pain or central sensitization as an indication of the drug.
Methods For Chronic Pain Management And Treatment Using Hcg
US Patent:
2012026, Oct 18, 2012
Filed:
Aug 16, 2011
Appl. No.:
13/211101
Inventors:
Constance T. Dutton - San Diego CA, US
International Classification:
G06Q 90/00, A61P 29/00, A61K 38/24
US Classification:
705500, 514 97
Abstract:
A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided with at least one of human chorionic gonadotropin (HCG), a pharmaceutically active HCG analogue, and a pharmaceutically active metabolite of the HCG or analogue at a dosage selected to provide, or be equivalent to, a human subcutaneous dosage of between 120 IU/day and 170 IU/day of HCG, and more preferably between 140 IU/day and 160 IU/day of HCG. A kit is also described, which includes a supply of the HCG-related drug, and a label that identifies chronic pain or central sensitization as an indication of the drug.
Methods For Chronic Pain Management And Treatment Using Hcg
US Patent:
2013019, Aug 1, 2013
Filed:
Oct 2, 2012
Appl. No.:
13/633739
Inventors:
Constance T. Dutton - San Diego CA, US
Assignee:
NEURALIGHT HD, LLC - Incline Village NV
International Classification:
A61K 38/24, A61M 5/315
US Classification:
514 98, 604506
Abstract:
A gonadotropin is administered within a surprisingly effective narrow range for the purpose of treating chronic pain or other central sensitization sequelae. In one aspect, a recipient is provided with at least one of human chorionic gonadotropin (uHCG and/or rHCG), a pharmaceutically active HCG analogue, and a pharmaceutically active metabolite of the HCG or analogue at a dosage selected to provide, or be equivalent to, a human subcutaneous dosage of between 120 IU/day and 170 IU/day of HCG, and more preferably between 140 IU/day and 160 IU/day of HCG. A kit is also described, which includes a supply of the HCG-related drug, a delivery device, and a label that identifies chronic pain or central sensitization as an indication of the drug.